Clinical, tumor, and product features associated with outcomes after axicabtagene ciloleucel therapy in follicular lymphoma.

J Clin Invest · 2025 · PMC12352890 · PMID 40536814

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

TMTV associated with worse PFS with a median cutoff of 403.7 mL ( Supplemental Figure 3B ), and optimal cutoff of 438.5 mL ( Supplemental Figure 3C ), while it only showed a trend of negative association with cutoff of 240 mL ( Supplemental Figure 3D ), which was previously used in ELARA study ( 5 ).

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.